YD Bio Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | LTM* |
|---|---|---|---|---|---|---|---|---|
| – | +106.6% | -48.7% | -51.6% | +46.6% | -7.2% | +10.0% | – | |
| – | – | – | – | – | – | – | – | |
| – | -3,353.9% | – | -87.3% | -80.8% | -905.6% | – | – | |
| – | – | +8.4% | -292.2% | – | – | -195.8% | – | |
| – | -3,281.3% | – | -87.2% | -80.9% | -906.0% | – | – | |
| – | -3,353.9% | – | -87.3% | -80.8% | -905.6% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.